Stephen Boyle

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood
Published: November 04, 2025

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood
Published: November 04, 2025

Rat bite fever diagnosed with clinical metagenomics.

Rat bite fever diagnosed with clinical metagenomics.

Journal: Pathology
Published: January 02, 2025

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

Journal: HemaSphere
Published: February 13, 2024

Epstein-Barr virus-associated lymphomas decoded.

Epstein-Barr virus-associated lymphomas decoded.

Journal: British journal of haematology
Published: July 28, 2023

Determinants of neonatal, infant and under-five mortalities: evidence from a developing country, Bangladesh.

Determinants of neonatal, infant and under-five mortalities: evidence from a developing country, Bangladesh.

Journal: Journal of public health policy
Published: April 02, 2023

All that glitters is not gold: pseudoplatelets associated with tumour lysis in high-blast-count AML.

All that glitters is not gold: pseudoplatelets associated with tumour lysis in high-blast-count AML.

Journal: Blood
Published: June 10, 2021

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.

Journal: HemaSphere
Published: May 05, 2021

Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.

Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.

Journal: European journal of haematology
Published: May 04, 2021

Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.

Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.

Journal: BMJ case reports
Published: February 24, 2019

Cutaneous seeding of neoplastic plasma cells to a site of bruising in a patient with relapsed myeloma.

Cutaneous seeding of neoplastic plasma cells to a site of bruising in a patient with relapsed myeloma.

Journal: British journal of haematology
Published: March 13, 2018

Sternoclavicular joint septic arthritis: an interesting lesson in clinical anatomy.

Sternoclavicular joint septic arthritis: an interesting lesson in clinical anatomy.

Journal: BMJ case reports
Published: October 10, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026